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Abstract: Scientific certainty regarding environmental toxin-related etiologies of breast 
cancer, particularly among women with genetic polymorphisms in estrogen metabolizing 
enzymes, is lacking. Fungicides have been recognized for their carcinogenic potential, yet 
there is a paucity of epidemiological studies examining the health risks of these agents.  
The association between agricultural fungicide exposure and breast cancer risk was 
examined in a secondary analysis of a province-wide breast cancer case-control study in 
Prince Edward Island (PEI) Canada. Specific objectives were: (1) to derive and examine 
the level of association between estimated fungicide exposures, and breast cancer risk 
among women in PEI; and (2) to assess the potential for gene-environment interactions 
between fungicide exposure and a CYP1A1 polymorphism in cases versus controls.   
After 1:3 matching of 207 cases to 621 controls by age, family history of breast cancer and 
menopausal status, fungicide exposure was not significantly associated with an increased 
risk of breast cancer (OR = 0.74; 95% CI: 0.46–1.17). Moreover, no statistically significant 
interactions between fungicide exposure and CYP1A1*2A were observed. Gene-environment 
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interactions were identified. Though interpretations of findings are challenged by 
uncertainty of exposure assignment and small sample sizes, this study does provide 
grounds for further research. 
Keywords: breast cancer; pesticides; fungicides; cytochrome p-450; estrogen metabolism; 
epidemiology; gene-environment interactions; GIS-based exposure  
 
1. Introduction 
Breast cancer is the most common female cancer in North America, excluding non-melanoma skin 
cancer [1,2]. Breast cancer risk is not fully explained by known genetic inheritance, menstrual and 
reproductive history, or other established risk factors. The identification of possible modifiable breast 
cancer risk factors, therefore, is of considerable interest, including those that interact with other known 
breast cancer risk factors [3]. 
Numerous epidemiological studies have assessed associations between pesticide exposures and 
breast cancer incidence [4–6]. The majority of these studies have either described pesticide exposure 
generically or have focused on organochlorine and organophosphate pesticides. There is a paucity of 
studies of fungicide exposure and breast cancer despite evidence that fungicides have been 
toxicologically classified as carcinogens and endocrine disruptors [7,8]. One cohort study reported a 
statistically significant relationship between breast cancer risk and fungicides among women who had 
never used pesticides, but whose husbands reported exposure to captan in farming applications in  
Iowa (RR = 3.2 95% CI: 1.8–5.6). Statistically significant associations between breast cancer risk and 
exposure to maneb or chlorothalonil, however, were not observed [9]. Though several studies have 
examined the role of putative environmental risk factors (PCBs, tobacco smoke) in gene-environment 
interactions and breast cancer, no identified gene-environment interaction study has assessed fungicide 
exposure [10–12].The relationship between CYP1A1 polymorphisms and breast cancer risk has been 
extensively studied. Several recent meta-analyses have reported that there is no over-all association 
with breast cancer risk for most of the common CYP1A1 polymorphisms. Associations in subpopulations 
or with specific environmental exposures, however, may still be important [13–16]. Associations 
between CYP1A1 polymorphisms and expression may occur through either changes in metabolism of 
estrogen or through changes in the metabolism of the environmental toxin. With regards to estrogen 
metabolism, CYP1A1 has been predominantly identified as being involved in the formation of the  
2-hydroxyestrogens, which exhibit lower estrogenic activity than the 4-hydroxyestrogens and   
16-alpha-hydroxy estrogens, metabolites that are believed to increase cancer risk [17]. Similarly, if 
metabolism of environmental toxins occurs at a higher rate in the presence of CYP polymorphisms, an 
individual’s risk of breast cancer may be elevated [18–20]. 
In this study, we chose to explore the possible interaction between a polymorphism in CYP1A1,  
a cytochrome p450 enzyme that is involved in estrogen and toxin metabolism [17], and fungicide 
exposure. The CYP1A1 subfamily has been shown to interact with many environmental contaminants, 
most commonly through either induction in response to exposure or through involvement in 
metabolism [21,22]. Due to the potential endocrine disrupting and carcinogenic potential of specific Int. J. Environ. Res. Public Health 2012, 9  1848 
 
 
fungicides, it is possible that this class of pesticides may impact breast cancer risk through either 
estrogenic or non-estrogenic pathways [7,8]. 
The present investigation is a further analysis of a recent case-control study that examined   
estrogen-metabolizing enzyme polymorphisms in relation to breast cancer incidence among women in 
Prince Edward Island (PEI) [23]. PEI provides a valuable study setting for this analysis as it is a rural 
province with a considerable percentage of land devoted to potato farming. The frequent use of 
fungicides on the potato fields and potential for atmospheric drift create potential for direct and 
residential exposure to these chemicals [24].  
2. Methods 
Specific objectives of this investigation were: (1) to assess the extent of association between breast 
cancer risk among PEI women and exposure to fungicides, derived using agricultural census data, land 
use files and geographic information systems (GIS) technology; (2) to explore the possibility of   
gene-environment interactions between breast cancer risk, CYP1A1 enzyme polymorphisms and 
fungicides. The study design and participant recruitment were approved by the Human Ethics Committee 
of the University of Prince Edward Island and the Ethics Committee of the Queen Elizabeth Hospital, 
Charlottetown, PEI, Canada.  
2.1. Study Population 
The study population was the same population described by Cribb et al. [23]. Incident breast cancer 
patients (cases) (n = 207) were recruited from recently diagnosed breast cancer patients referred to the 
Queen Elizabeth Hospital (QEH) Medical Oncology Unit, in Charlottetown between July 1999 and 
March 2002 and referent participants (controls) (n = 621) were recruited from women presenting for 
routine mammography screening through the QEH Mammography Screening Program during the same 
period. As noted in Cribb et al. [23], 1,216 controls were recruited in the original case-control study, 
one withdrew from the study prior to analysis and sufficient DNA for analysis was not obtained   
from 12 recruits. Thirty-nine controls were identified as having breast cancer at the time of screening 
and, therefore, became cases. Of the 179 initial cases recruited from the oncology unit, seven were 
excluded due to inability to find appropriate matches and four were excluded because of insufficient  
DNA samples. Thus, 207 cases (168 initial cases plus 39 initial controls) and 621 controls were 
included in the final analysis. All study participants completed the study questionnaire during their 
clinic visit, thus non-response bias is not a concern. Women who had no previous personal history of 
breast cancer or abnormal mammography and were full time residents of PEI at the time of screening 
were eligible as controls. Controls were frequency matched 3:1 with cases on age (±5 years), 
menopausal status (current yes/no), and family history of breast cancer (mother, sister or daughter with 
breast cancer (current yes/no)). As the primary objective of the original case-control study was to 
assess the influence of single nucleotide genetic polymorphisms on risk of breast cancer, cases and 
controls were matched on age, family history of breast cancer, and menopausal status to facilitate 
analysis of the more subtle genetic influences on breast cancer risk [23].  
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2.2. Exposure Assessment 
Fungicide exposure levels were derived using 1991 Canadian Agricultural Census data and census 
boundary files. The Agricultural Census provides data on the number of hectares in each consolidated 
census subdivision (CCS) that were treated with any fungicides. With these data, a continuous spatial 
surface of exposure, the percentage of land per CCS to which fungicides were applied, was developed 
using geographic information system (GIS) based methods [25]. The mean number of hectares per 
CCS (n = 64) was 6,930 (standard deviation 2,323) with a range of 3,557–12,782. Although there was 
some heterogeneity in the size of CCSs, this geographic unit of analysis was felt to have utility as a 
regional indicator of exposure. 
Specific data on the type of fungicide used was not available from the census. All Canadian farm 
operators that produce agricultural products intended for sale, regardless of income, are asked to 
complete the Canadian Census of Agriculture. This census year was chosen to represent a 10 year 
estimated latency period between fungicide exposure and breast cancer diagnosis [26]. Moreover, as 
the census is only conducted every 10 years, it was determined that 1991 represented the most feasible 
and appropriate time period.  
Participants provided their postal code, not residential address, in the original case-control study 
questionnaire. Thus, postal code, as a surrogate for residence, was mapped to the corresponding   
CCS using GIS, giving a percentage of land to which fungicide was applied for each participant’s CCS.  
To allow for evaluation of multiple perspectives on the exposure disease relationship, fungicide 
exposure was analyzed as a continuous, binary, and categorical variable. The continuous exposure 
variable (percentage of land to which fungicide was applied) for each participant’s CCS was 
transformed into binary and categorical variables by assessing the frequency pattern of exposure 
among controls for notable changes in slope or breaks in the curve with cutoff assigned to minimize 
exposure misclassification. Using this technique, the binary variable was developed by assigning   
CCS with 10% or less of land treated with fungicides as low exposure and greater than 10% as high 
exposure. The histogram of exposure demonstrated a cluster of study participants below 10% and a 
scattered distribution of participants above 10%. Moreover, the selection of 10% as the cut-off point 
identified 14% of cases and 18% of controls as having high exposure. Selecting a higher cut-off point 
would have resulted in subgroups that were too small for analysis and selecting a lower cut-off point 
might not have isolated those individuals with high exposure. The categorical variables determined 
high exposure as greater than 10%, medium exposure as greater than or equal to 4.5% but less than or 
equal to 10%, and low exposure was determined to be less than 4.5%. These cutoff points were 
similarly determined by assessing the pattern of exposure distribution. As the objective of the original 
case-control study was to assess the influence of single nucleotide genetic polymorphisms on risk of 
breast cancer, there was no direct measurement of fungicide exposure during the initial study, nor 
structured collection of histories of past personal, residential or occupational exposures to fungicides 
as part of the questionnaire [23]. 
2.3. Genetic Polymorphism Data 
Detailed methods for obtaining the genetic polymorphism data can be found in the original paper [23]. 
Buccal cells for DNA analysis were prepared using the protocol described by Richards et al. [27]. Int. J. Environ. Res. Public Health 2012, 9  1850 
 
 
Genotyping of the CYP1A1*2A polymorphism (T3801C) was completed by PCR-RFLP according to 
the methods described by Bailey et al. [28] and then confirmed by the use of the National Cancer 
Institute Cancer Genome Anatomy Project validated Taqman
® assay for CYP1A1 using primers and 
probes purchased from Applied Biosystems Inc (Assay number A-015943).  The CYP1A1*2A data 
were categorized into (1) homozygous referent and (2) heterozygous and homozygous variant alleles 
such that any influence of the variant allele was captured in the non-referent category. The heterozygous 
and homozygous variant alleles were grouped together in this manner to ensure sufficient sample size 
for comparison in the variant group. 
2.4. Data Analysis 
Descriptive statistics were calculated to compare effectiveness of matching variables (age, 
menopausal status, family history of breast cancer) and to assess breast cancer risk factor information. 
Crude odds ratios, t-tests and chi-square tests were examined to determine which variables were 
statistically significant associated with breast cancer risk. Covariates that did not change the effect 
estimate of fungicides on breast cancer risk by more than 10% were not included in the final logistic 
regression model. As cases and controls in this study were frequency matched, the analysis utilized 
unconditional logistic regression and included the matching variables [29]. Two models were developed. 
Model I  Analysis of the association between fungicide exposure and breast cancer risk adjusting 
for matching variables. Separate models were run for fungicide exposure as a binary, 
categorical and continuous variable. 
Model II  Analysis of the association between CYP1A1 as a main effect and breast cancer risk, 
adjusting for matching variables. We explored the potential for a gene-environment 
interaction between the three fungicide exposure variables and the CYP1A1*2A allele by 
adding a multiplicative interaction term to the model and assessing the significance of the 
p value (Wald test) of the interaction term. All analyses were performed using   
SAS v 9.2 [30]. 
3. Results and Discussion 
3.1. Descriptive Statistics 
Matching of cases to controls according to age, family history of breast cancer, and menopausal status 
categories, proved to be effective; the distribution of these characteristics among cases and controls was 
nearly identical. Cases were significantly more likely to have a BMI greater than 25 at time of study 
enrollment, fewer children, and to have had an ovariectomy prior to age 45. Descriptive analysis also 
identified that cases were less likely (p value = 0.09) to ever use oral contraceptives (OC) (Table 1). As 
none of these four covariates changed the effect estimate of fungicide exposure on breast cancer risk 
by more than 10%, they were not included in the multivariate logistic regression models   
reported below. 
  Int. J. Environ. Res. Public Health 2012, 9  1851 
 
 
Table 1. Univariate analysis of association between sociodemographic and lifestyle 
covariates and breast cancer risk, PEI, 1999–2003. 
Variable 
Level of 
Variable 
Cases Mean 
(95% CI) 
Controls Mean 
(95% CI) 
Crude 
Odds Ratio 
95% CI  p value 
1 
Age    
54.6 
(53.1–56.1) 
55.0 
(54.1–55.8) 
0.99 0.98,  1.01  0.67 
Duration of 
Residence on PEI 
(years) 
 
44.1 
(41.4–46.7) 
42.7 
(41.3–44.2) 
1.00 0.99,  1.01  0.40 
Age at Menarche 
(years) 
 
12.9 
(12.7–13.1) 
13.0 
(12.8–13.1) 
0.96 0.86,  1.07  0.52 
    N (%)  N (%)       
Positive Family 
History of Breast 
Cancer  
Yes 
No 
53 (25.6) 
154 (74.4) 
159 (25.6) 
462 (74.4) 
1.0 0.70,  1.43  1.0 
Menopausal  
status 
Post 
Pre 
127 (61.4) 
80 (38.7) 
381 (61.4) 
240 (38.7) 
1.0 0.72,  1.38  1.0 
Ethnicity 
Caucasian 
Other 
207 (100) 
0 
621 (100) 
0 
NA   
Birthplace 
PEI 
Other 
150 (72.4) 
57 (27.5) 
472 (76.1) 
148 (23.9) 
0.82 0.57,  1.18  0.30 
Body Mass Index 
(at time of 
recruitment) 
BMI ≤25 
BMI >25 
61 (30.2) 
141 (69.8) 
244 (39.80) 
369 (60.20) 
1.53 1.09,  2.15  0.01 
Number of Children 
None 
1–3 
>4 
31 (15.1) 
137 (66.5) 
38 (18.5) 
64 (10.3) 
389 (62.6) 
168 (27.1) 
1.0 
0.73 
0.47 
0.45, 1.17 
0.27, 0.81 
0.01 
Ovariectomy at  
<45 Years of Age 
No 
Yes 
195 (94.2) 
12 (5.8) 
546 (88.2) 
73 (11.8) 
0.46  0.24, 0.87 0.01 
Oral Contraceptive 
Use 
Never 
Ever 
69 (33.5) 
137 (66.5) 
170 (27.4) 
451 (72.6) 
1.0 
0.75 
0.53, 1.05 0.09 
Currently Drink 
Alcohol  
Yes 
No 
129 (62.9) 
76 (37.1) 
348 (56.7) 
271 (43.8) 
1.32 0.95,  1.83  0.09 
1 p value from t-test for continuous variables and Chi-square test for categorical variables 
3.2. Model I Association Between Breast Cancer Risk and Fungicide Exposure 
After adjusting for matching variables in an unconditional multivariable logistic regression model, 
there was no statistically significant association between any of the fungicide exposure variables and 
breast cancer risk (Table 2). In both the binary and categorical variable, a higher percentage of controls 
(18%) than cases (14%) had high levels of exposure but a higher percentage of cases (16%) than controls 
(13%) had medium exposure in the categorical variable, though these finding were not significant. 
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Table 2. Unconditional multivariable logistic regression models 
a of association between 
breast cancer risk and fungicide exposure, PEI, 1999–2003. 
Variable 
Level 
of Variable 
Cases 
N (%) 
Controls 
N (%) 
Adjusted 
Odds Ratio 
95% CI 
Fungicide Exposure 
(continuous) 
--  207 617 0.98  0.97–1.01 
Fungicide Exposure  
Low 
High 
178 (85.9) 
29 (14.1) 
507 (81.6) 
114 (18.4) 
1.0 
0.72 
0.46–1.12 
Fungicide Exposure 
Low 
Medium 
High 
145 (70.0) 
33 (15.9) 
29 (14.01) 
426 (68.6) 
81 (13.04) 
114 (18.4) 
1.0 
1.19 
0.74 
 
0.76–1.87 
0.47–1.17 
a Adjusted for matching variables (age, menopausal status, family history of breast cancer). 
3.3. Model II. Association Between Breast Cancer Risk, Fungicide Exposure and CYP1A1*2A 
The odds ratio between CYP1A1*2A and breast cancer risk was observed to be 0.78   
(95% CI 0.55–1.13). Product terms between CYP1A1*2A and fungicide exposure were not significant 
in any of the exposure models (Table 3). The p value (Wald test) was smallest for the continuous 
exposure*CYP1A1*2A product term (0.14) and greatest for the categorical exposure*CYP1A1*2A 
product term (0.71) suggesting that the results were highly influenced by the low power in the 
exposure subgroups (Table 3).  
Table 3. Unconditional multivariable logistic regression analysis of association between 
breast cancer risk, fungicide exposure and CYP1A1*2A allele, PEI, 1999–2003. 
Variable 
Level of 
Variable 
Cases  
N (%) 
Controls  
N (%) 
Odds 
Ratio 
95% CI  Product Term  p value 
CYP1A1*2A 
a 
Referent 
Variant 
160 (78.4%) 
44 (21.6%) 
465 (75.0) 
154 (25.0) 
0.78 0.55–1.13  --  -- 
CYP1A1*2A 
b 
Referent 
Variant 
160 (78.4%) 
44 (21.6%) 
465 (75.0) 
154 (25.0) 
0.78 0.55–1.13 
CYP1A1*2Ax 
Continuous 
Exposure 
0.14 
CYP1A1*2A 
c 
Referent 
Variant 
160 (78.4%) 
44 (21.6%) 
465 (75.0) 
154 (25.0) 
0.79 0.55–1.12 
CYP1A1*2Ax 
Binary Exposure 
0.22 
CYP1A1*2A 
d 
Referent 
Variant 
160 (78.4%) 
44 (21.6%) 
465 (75.0) 
154 (25.0) 
0.78 0.55–1.13 
CYP1A1*2Ax 
Categorical 
Exposure 
0.71 
a Adjusted for matching variables (age, menopausal status and family history of breast cancer);   
b Adjusted for matching variables and continuous fungicide exposure; 
c Adjusted for matching variables 
and binary fungicide exposure; 
d Adjusted for matching variables and categorical fungicide exposure. 
3.4. Discussion 
This further analysis of the PEI Breast Cancer Study was one of only a few case-control 
epidemiological investigations of fungicide exposure and breast cancer risk and the first to examine 
gene-environment interactions for genetic polymorphisms in p450 enzymes in relation to fungicide 
exposure. Though the present investigation did not identify a statistically significant association Int. J. Environ. Res. Public Health 2012, 9  1853 
 
 
between fungicide exposure and breast cancer risk, toxicological evidence exists to support the role of 
fungicides as carcinogens and endocrine disruptors [7,8]. Chlorothalonil, one of the primary fungicides 
used on PEI, has been classified as a probable carcinogen by the U.S. EPA [7]. The primary metabolite 
of chlorothalonil (4-hydroxy-2,5,6-trichloroisophthalonitrile), known as DS-3701, has greater toxicity 
than its parent compound, as observed from wildlife studies [31]. The two other predominantly used 
fungicides on PEI, metiram and mancozeb, are both ethylene bisdithiocarbamates fungicides (EBDC) 
and have been classified as endocrine disruptors. Toxicological studies have observed that exposure to 
mancozeb induces apoptosis, thus providing a mechanistic link between mancozeb and cancer [32,33]. 
Moreover, the metabolite of EBDC fungicides, ethylene thiourea, has been classified as a   
carcinogen [34]. A cohort study that examined the association between maneb or chlorothalonil 
exposure and breast cancer risk did not identify an association between ever vs. never use of either 
chlorothalonil and breast cancer risk though this study was also limited by small samples sizes of 
exposed cases [9]. Metiram and mancozeb, the two other primary fungicides used in PEI were not 
assessed in the Iowa/North Carolina cohort study.  
The present investigation’s observed that fungicide exposure was not statistically significantly 
associated with breast cancer risk. The trend in the models with binary and categorical exposure 
variables was towards a reduced risk of breast cancer risk among women with elevated levels of 
exposure. A biologically plausible explanation for this finding could be that fungicides inhibit the  
CYP p450 system and thus lessen the concentration of estrogen metabolites. Toxicological literature 
has reported that maneb, an EBDC fungicide with a chemical structure similar to mancozeb, inhibits 
CYP p450 enzymes, yet other supportive literature is lacking [35]. On the contrary, it is more likely 
that the potential carcinogenic effects of fungicides were not observed due to the limitations in sample 
size, bias, and misclassification. Further toxicological and epidemiological evidence is needed to 
clarify the relationship between fungicide exposure and adverse health outcomes.  
The analysis of the interaction between fungicide exposure and CYP1A1*2A did not identify a 
significant product term for any of the exposure variables. As a main effect, presence of the 
heterozygous and homozygous variant CYP1A1*2A  alleles suggested an inverse association with 
breast cancer risk, though was not statistically significantly. Biological interpretation of these observed 
findings is again limited due to the low sample size and potential influences of bias. 
While no previous research reported in the literature has examined the interaction between 
fungicide exposure and the CYP1A1*2A allele in relation to breast cancer risk, studies of   
PCB exposure demonstrated that neither CYP1A1*2C status nor PCB exposure were independently 
associated with increased breast cancer risk [10,11]. However, women with the variant CYP1A1*2C 
allele who had the highest level of PCB exposure experienced an increased risk of breast cancer. 
Similarly, Li et al. [36] reported a trend among women with elevated levels of pesticide exposure 
towards increased breast cancer risk among subgroups of women with the CYP1A1*2C and   
CYP1A1*3 alleles.  
In seeking an explanation for our findings, it is necessary to consider the dual role of CYP1A1 
activity. On the one hand, as CYP1A1 is induced by many environmental contaminants, induction may 
increase the rate of estrogen metabolism toward the 2-hydroxyestrogens and away from the more 
estrogenic metabolites [12]. In this scenario, the interaction between the environmental exposure and 
the variant CYP1A1*2A allele could play a protective role because of an even greater activity of Int. J. Environ. Res. Public Health 2012, 9  1854 
 
 
CYP1A1. On the other hand, CYP1A1 has the potential to activate environmental toxins leading to an 
increased exposure to potentially toxic metabolites [37]. This latter role of CYP1A1 is particularly 
relevant to the present investigation as the metabolites of both EBDC fungicides (ethylene thiourea) 
and chlorothalonil (DS-3701) are more toxic than the parent compounds. In this case, women with the 
variant allele may be at an increased risk of breast cancer due to an elevated concentration of these 
toxic metabolites. The possible relationships or interactions are therefore complex, and it is not 
possible to speculate from the current data on biological mechanisms or the significance of the   
putative association. 
3.5. Strengths and Limitations 
The primary strength of this investigation is the analysis of an understudied class of pesticides in a 
relatively high-exposure intensity geographical region. Moreover, the availability of detailed lifestyle 
and covariate data from the PEI case-control study allowed this investigation to evaluate potential 
confounding due to established breast cancer risk factors and the presence of genetic polymorphism 
data facilitated the analysis of gene-environment interactions. 
In addition, PEI provides a valuable study setting due to the presence of a national healthcare 
system and relatively homogenous population. All residents of the island are provided with universal 
access to the national healthcare system, thus eliminating any financial or insurance barriers to 
screening or treatment. At the time of the study, the Queen Elizabeth Hospital was the primary 
oncology clinic and all breast cancer diagnoses on the island were recorded in the PEI cancer registry. 
During the study time period, 345 breast cancer diagnoses were recorded in the PEI cancer registry. 
The case-control study recruited 207 (60%) of these breast cancer cases, the geographic distribution of 
residential addresses of the case population was examined and shown to be representative of the 
overall pattern of disease on the island. In contrast to communities lacking a national healthcare 
system, women who reside in PEI may be more likely to seek routine mammography screening. Rates 
of mammography screening have been reported at 56% on the island [38]. The QEH mammography 
clinic is one of only two screening centers on the island. The QEH mammography clinic is located in 
the capital city, Charlottetown, and has two diagnostic imaging machines, whereas the screening clinic 
in Summerside is located in a community with lower population density and only one machine. It is 
estimated that two-thirds of PEI women undergo mammography screening at the QEH clinic. 
Moreover, more than 50% of the consolidated census subdivisions in PEI were represented by the 
study population (as indicated by a case or control residing in that subdivision). Thus, cases and 
controls provide a reasonable representation of the same underlying source population on the island. 
The present investigation is, however, challenged by some exposure misclassification, and small 
sample size. While the use of the Agricultural Census data was a feasible means of assessing regional 
levels of fungicide exposure retrospectively, these data did not permit analysis of individual level 
exposure to specific fungicides. Moreover, reliance on postal code rather than individual residential 
address may have inappropriately assigned certain individuals to a CCS if they lived at the border of 
the CCS or collected their mail in a different location than where they resided, leading to errors in the 
percentage of hectares receiving fungicides assigned to some participants. These limitations highlight 
the challenges of utilizing a geographic based approach to exposure assessment. The inclusion of  Int. J. Environ. Res. Public Health 2012, 9  1855 
 
 
time-activity personal exposure histories and measurements of specific fungicides in environmental 
media would enhance precision of such analyses in future studies, but was not possible in this 
retrospective analysis of secondary data. 
There are other considerations that must be taken into account in interpreting these results. PEI is 
relatively small, and given the extent to which fungicides are sprayed across the Island, the entire 
population may have in fact been exposed to elevated fungicide concentrations, as suggested by 
fungicide ambient air quality studies conducted by Environment Canada [39]. The inclusion of an 
external, off-Island control group would have strengthened the interpretation of study findings, but an 
external control group was not part of the original study. Moreover, while recruitment of the control 
population from the mammography clinic did minimize the potential for outcome misclassification 
among controls, this strategy does present potential selection bias as it may inadvertently exclude 
women who do not seek healthcare from the study population. 
Lastly, the study was underpowered to detect associations between the estimated fungicide 
exposure and breast cancer risk, although the sample size was limited by the sample size of the original 
study. Utilizing the percent of exposure among cases and controls from the binary exposure variable, 
the study had 25% power to detect the observed associations, thus the likelihood of a Type 2 error is 
notably high. Moreover, the analysis of the interaction between CY1A1*2A polymorphisms and 
fungicide exposure also lacked sufficient power to make conclusive observations about the findings.  
4. Conclusions 
While there is limited data on relationships between breast cancer risk and exposure to insecticides 
and herbicides, there is a greater paucity of data for fungicides despite evidence of their toxic and 
endocrine disrupting properties. This investigation provided a valuable initial opportunity to explore 
such associations in relation to genetic predisposition and breast cancer risk in a region of documented 
intensive agricultural fungicide application. Fungicide exposure was not found to be significant 
associated with an increased risk of breast cancer, and no statistically significant gene-environment 
interactions were identified. Environmental fungicide metrics would have been enhanced by more 
precise exposure assessment methodologies. Further investigation into the health effects of this class of 
pesticides is warranted. 
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